These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 6292093

  • 1. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC, Dorval G, Menezes J.
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E, Jondal M.
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [Abstract] [Full Text] [Related]

  • 3. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
    Bakacs T, Svedmyr E, Klein E.
    Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
    [Abstract] [Full Text] [Related]

  • 4. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
    Maeda M, Sairenji T, Hinuma Y.
    Microbiol Immunol; 1979 Apr; 23(12):1189-97. PubMed ID: 231730
    [Abstract] [Full Text] [Related]

  • 5. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M, Kato M, Ikeno K, Kobayashi T, Miyagawa Y, Komiyama A, Akabane T.
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [Abstract] [Full Text] [Related]

  • 6. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
    Ebihara T, Sakai N, Koyama S.
    Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M, Benninger-Döring G, Prang N, Sylla BS, Laumbacher B, Wank R, Wolf H, Schwarzmann F.
    Int J Cancer; 1998 May 29; 76(5):694-701. PubMed ID: 9610728
    [Abstract] [Full Text] [Related]

  • 11. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK, Haworth SJ, Cohen J, Mundin J, Rickinson A, Sissons JG.
    Q J Med; 1986 Feb 29; 58(226):111-21. PubMed ID: 3012622
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Absence of Epstein-Barr virus-specific, HLA class II-restricted CD4+ cytotoxic T lymphocytes in infectious mononucleosis.
    Enssle KH, Fleischer B.
    Clin Exp Immunol; 1990 Mar 29; 79(3):409-15. PubMed ID: 1690617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I, Sullivan JL, Periman PO, Perlin E.
    N Engl J Med; 1975 Dec 04; 293(23):1159-63. PubMed ID: 171568
    [Abstract] [Full Text] [Related]

  • 16. Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
    Klein E, Masucci MG.
    Springer Semin Immunopathol; 1982 Dec 04; 5(1):63-73. PubMed ID: 6314570
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
    Menezes J, Jondal M, Leibold W, Dorval G.
    Infect Immun; 1976 Feb 04; 13(2):303-10. PubMed ID: 177360
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.
    Blazar B, Patarroyo M, Klein E, Klein G.
    J Exp Med; 1980 Mar 01; 151(3):614-27. PubMed ID: 6244358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.